SIADH

11 registered clinical trials studyying SIADH — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Low-dose Tolvaptan for Inpatient Hyponatraemia. NCT06171100	King's College Hospital NHS Trust	—
Completed	Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome NCT05055856	Universitair Ziekenhuis Brussel	N/A
Recruiting	Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia NCT04447911	University Hospital, Basel, Switzerland	Phase 4
Active Not Recruiting	Urea Therapy for Hyponatremia in Subarachnoid Hemorrhage NCT04552873	University Hospital, Grenoble	N/A
Completed	Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia NCT04744987	Hospital San Carlos, Madrid	—
Completed	Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study NCT02874807	University Hospital, Basel, Switzerland	Phase 2 / Phase 3
Terminated	Tolvaptan for Patients With Acute Neurological Injuries NCT02545114	Polderman, Kees, H., MD, PhD	N/A
Unknown	The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia NCT01509170	Hadassah Medical Organization	—
Withdrawn	Fractional Urate Excretion in Nonedematous Hyponatremia NCT01425125	NYU Langone Health	N/A
Unknown	Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference St NCT04409626	Zealand University Hospital	—
Unknown	Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice NCT01228682	Otsuka Frankfurt Research Institute GmbH	—